TLO - Delayed Quote EUR

AGILENT TECHNOLOGIES (4A.TI)

92.98

-0.85

(-0.91%)

At close: May 6 at 4:41:43 PM GMT+2

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Agilent (NYSE:A) and its peers.

StockStory 19 days ago

A

TECH

AVTR
Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks 26 days ago

A

CNC
Heidi Kunz Resigns From Agilent Technologies (NYSE:A) Board as Share Price Falls 3%

Last week, Agilent Technologies (NYSE:A) experienced a price decline of 3%, a movement that may have been influenced by recent changes within the company's board. The announcement of Heidi Kunz's impending resignation from the board and its committees could have introduced some uncertainty, potentially impacting investor sentiment. Additionally, the broad market impact from President Trump's announcement of new tariffs, which saw significant declines in major indices like the Dow Jones and...

Simply Wall St. last month

A
Are Investors Undervaluing Agilent Technologies, Inc. (NYSE:A) By 24%?

Key Insights The projected fair value for Agilent Technologies is US$154 based on 2 Stage Free Cash Flow to Equity...

Simply Wall St. last month

A
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

SANTA CLARA, Calif., March 24, 2025--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL®, a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the xCELLigence Real-Time Cell Analysis (RTCA) technology, was applied in developing and validating AUCATZYL. The xCELLigence RTCA technology supported the development and implementation of the potency assay. By providing precise and

Business Wire last month

A
CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

SANTA CLARA, Calif., March 20, 2025--Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph.

Business Wire last month

A
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

SANTA CLARA, Calif., March 19, 2025--Agilent Technologies Inc. (NYSE: A) today announced that Columbia University has received an Agilent Research Catalyst (ARC) Award on behalf of Dr. Pawel Muranski, an internationally recognized researcher and physician-scientist specializing in bone marrow transplant (BMT) and cancer cellular immunotherapy.

Business Wire last month

A
Agilent Technologies (NYSE:A) Expands Cancer Diagnostic Kit Indications In EU For NSCLC And Melanoma

Agilent Technologies (NYSE:A) recently achieved EU IVDR approval for two new indications of its PD-L1 IHC 28-8 pharmDx kit, expanding treatment options for early-stage NSCLC and advanced melanoma. While this significant advancement in oncology diagnostics highlights the company's innovative edge, Agilent's stock saw a weekly decline of 3.51%. This price movement occurred against a backdrop of broader market volatility, driven by economic and political uncertainties including the Trump...

Simply Wall St. last month

A
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

SANTA CLARA, Calif., March 10, 2025--Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU IVDR1, expanding the eligibility of treatment to early-stage non-small cell lung cancer (NSCLC) and previously untreated advanced melanoma patients. These two new indications bring the total indications launched in Europe for PD-L1 IHC 28-8 pharmDx to nine. PD-L1 IHC 28-8 pharmDx is approved for exclusive

Business Wire last month

A
Agilent to Participate in TD Cowen Health Care Conference

SANTA CLARA, Calif., February 28, 2025--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at TD Cowen's 45th Annual Health Care Conference at 9:50-10:20 a.m. Eastern on Tuesday, March 4, 2025, in Boston, Massachusetts.

Business Wire 2 months ago

A
Is Now An Opportune Moment To Examine Agilent Technologies, Inc. (NYSE:A)?

Agilent Technologies, Inc. ( NYSE:A ) saw significant share price movement during recent months on the NYSE, rising to...

Simply Wall St. 2 months ago

A
Agilent Reports First-Quarter Fiscal Year 2025 Financial Results

SANTA CLARA, Calif., February 26, 2025--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, representing growth of 1.4% reported and up 1.2% core(1) compared to the first quarter of 2024.

Business Wire 2 months ago

A
Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 2 months ago

E

EIPAF

SJM
Agilent Announces Cash Dividend of 24.8 Cents per Share

SANTA CLARA, Calif., February 19, 2025--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on April 23, 2025, to all shareholders of record as of the close of business on April 1, 2025.

Business Wire 2 months ago

A
Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26

SANTA CLARA, Calif., January 24, 2025--Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST.

Business Wire 3 months ago

A
Agilent Automated Workflows at SLAS2025: Connecting with Confidence

SANTA CLARA, Calif., January 24, 2025--Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Exhibition being held January 25-29, at the San Diego Convention Center in California. Agilent is a leader in advancing automation solutions to help customers optimize lab performance, efficiency, and reproducibility across their entire pipeline, from research and drug discovery to development and ma

Business Wire 3 months ago

A
Agilent Technologies, Inc.'s (NYSE:A) Stock Been Rising: Are Strong Financials Guiding The Market?

Agilent Technologies' (NYSE:A) stock up by 3.8% over the past week. Given that the market rewards strong financials in...

Simply Wall St. 3 months ago

A
Two Agilent Factories Among 13 to Join World Economic Forum Lighthouse Network

Agilent Technologies Inc. (NYSE: A) today announced the World Economic Forum has named two of Agilent's smart factories in Asia as a Global Lighthouse Network, a community of 189 global leaders leading the way in the Fourth Industrial Revolution (4IR) in advanced manufacturing.

PR Newswire 3 months ago

A
Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists

SANTA CLARA, Calif., January 13, 2025--Agilent Technologies Inc. (NYSE: A) today announced Solutions Innovation Research Awards (SIRA) have been presented to Professor Anders Bentien of Aarhus University, Professor Walter Gössler of University of Graz, and Professor Gregory Offer of Imperial College London. These separate awards recognize their outstanding contributions to battery research.

Business Wire 3 months ago

A
Jim Cramer on Agilent Technologies, Inc. (A): ‘They Told A Pretty Good Story’

We recently compiled a list of the 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Agilent Technologies, Inc. (NYSE:A) stands against the other stocks. Jim Cramer, the host of Mad Money, recently shared some investment guidelines based on his 40 years of experience. As we previously […]

Insider Monkey 4 months ago

A

Performance Overview

Return	4A.TI	MSCI WORLD (^990100-USD-STRD)
YTD	-28.22%	-0.38%
1-Year	-28.81%	+8.78%
3-Year	-17.08%	--

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

AGILENT TECHNOLOGIES (4A.TI)

Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Heidi Kunz Resigns From Agilent Technologies (NYSE:A) Board as Share Price Falls 3%

Are Investors Undervaluing Agilent Technologies, Inc. (NYSE:A) By 24%?

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

Agilent Technologies (NYSE:A) Expands Cancer Diagnostic Kit Indications In EU For NSCLC And Melanoma

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Agilent to Participate in TD Cowen Health Care Conference

Is Now An Opportune Moment To Examine Agilent Technologies, Inc. (NYSE:A)?

Agilent Reports First-Quarter Fiscal Year 2025 Financial Results

Stocks to watch this week: Berkshire Hathaway, Nvidia, Salesforce, IAG and Aston Martin

Agilent Announces Cash Dividend of 24.8 Cents per Share

Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26

Agilent Automated Workflows at SLAS2025: Connecting with Confidence

Agilent Technologies, Inc.'s (NYSE:A) Stock Been Rising: Are Strong Financials Guiding The Market?

Two Agilent Factories Among 13 to Join World Economic Forum Lighthouse Network

Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists

Jim Cramer on Agilent Technologies, Inc. (A): ‘They Told A Pretty Good Story’

Performance Overview